Samson Clinical ( Samson ), an Australian pharmaceutical company focused on developing innovative treatments for hair loss, today announced the successful completion of recruitment ...
ACEI and ARB use in CKD has been available for over three decades, but it is still underutilized. Now, a new clinical ...
Early results show 70% accuracy of AI-assisted detection of unexplained male infertility using Asian IVF data.
A new study published in the Journal of the American Heart Association has found that women patients with culture-negative ...
Researchers sought to determine whether glofitamab would induce responses in real-world cases of relapsed or refractory DLBCL.
Identify the clinical and historical risk factors for persistent postconcussive symptoms 30 days post-mTBI in adults presenting to the ED, including female sex, history of migraine/headache, and ...
The survival rates of people with early onset dementia—diagnosed before the age of 65—vary considerably by clinical type, but ...
LAS VEGAS, Nov. 4, 2025 /PRNewswire/ -- The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, ...
Mortality/major ischemic events at 90 days were no lower than with a restrictive strategy—but cardiac complications differed.
The findings position SII as a potentially valuable biomarker for risk stratification in patients with COPD and AF, with the identified threshold potentially serving as a clinical decision point for ...
The drug, given as a weekly subcutaneous injection, reduced both triglycerides and liver fat in the phase II trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback